首页|lncRNA-miR210HG在NSCLC患者癌组织中的表达及其临床意义

lncRNA-miR210HG在NSCLC患者癌组织中的表达及其临床意义

扫码查看
目的 分析非小细胞肺癌(NSCLC)患者癌组织中长链非编码RNA(lncRNA)-miR210HG的表达及其临床意义。方法 选取84 例NSCLC患者,比较其癌组织及癌旁组织中lncRNA-miR210HG水平。按照lncRNA-miR210HG表达水平将患者分为高表达组和低表达组,比较两组临床病理参数和生存情况。多因素COX回归模型分析影响NSCLC患者预后的危险因素。结果 NSCLC癌组织miR210 和lncRNA-miR210HG表达水平均高于癌旁组织(P<0。05)。Ⅲ期、存在淋巴结转移的患者癌组织中lncRNA-miR210HG高表达者占比较高(P<0。05),高表达组总生存率和无进展生存率低于低表达组(P<0。05)。lncRNA-miR210HG是影响NSCLC患者预后的独立危险因素(P<0。05)。结论 NSCLC癌组织中lncRNA-miR210HG高表达与有无淋巴转移、临床分期有关,lncRNA-miR210HG是影响NSCLC患者预后的独立危险因素。
Expression and clinical significance of lncRNA-miR210HG in cancer tissues of NSCLC patients
Aim To analyze the expression and clinical significance of long non-coding RNA(lncRNA)-miR210HG in cancer tissues of patients with non-small cell lung cancer(NSCLC).Methods A total of 84 patients with NSCLC were enrolled.The level of lncRNA-miR210HG in cancer tissues and para-carcinoma tissues was compared.According to average expression level of lncRNA-miR210HG,patients were divided into high-expression group and low-expression group,respectively,and clinicopathologi-cal parameters and survival in these two groups were compared.The risk factors affecting prognosis of NSCLC patients were analyzed by multivariate COX regression model.Results The expression levels of miR210 and lncRNA-miR210HG in cancer tissues were higher than those in para-carcinoma tissues(P<0.05).The proportion of high-expression lncRNA-miR210HG was higher in patients with clinical staging at stage Ⅲ and lymph node metastasis(P<0.05).The overall survival rate and progression-free survival rate in high-expression group were lower than those in low-expression group(P<0.05).The lncRNA-miR210HG was an independent risk factor to affect prognosis of NSCLC patients(P<0.05).Conclusion The high expression of lncRNA-miR210HG in cancer tissues is related to lymph node metastasis and clinical staging in NSCLC.The lncRNA-miR210HG is an independent risk factor to affect prognosis of NSCLC patients.

non-small cell lung cancercancer tissuelncRNA-miR210HGclinicopathological parameter

马方旭、邹芳、赵娟、刘亚群、王布

展开 >

河北省胸科医院呼吸与危重症医学科,河北石家庄 050041

河北北方学院附属第一医院呼吸与危重症医学科,河北张家口 075000

非小细胞肺癌 癌组织 lncRNA-miR210HG 临床病理参数

河北省医学科学研究项目

20231415

2024

中南医学科学杂志
南华大学

中南医学科学杂志

CSTPCD
影响因子:0.757
ISSN:2095-1116
年,卷(期):2024.52(2)
  • 14